Intelligence Β· Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs Β· EMA approved Β· by data quality Β· Page 35 of 39

  1. pertussis vaccine (recombinant, acellular, component, adsorbed)

    VACPERTAGEN

    EMA: approved

    J07AJ02
  2. phenylephrine

    OMIDRIA

    EMA: approved

    S01
  3. piflufolastat (18f)

    PYLCLARI

    EMA: approved

    V09
  4. piperaquine tetraphosphate

    EURARTESIM

    EMA: approved

    P01BF05
  5. pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)

    PREVENAR 13

    EMA: approved

    J07AL02
  6. pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)

    PREVENAR 20 (PREVIOUSLY APEXXNAR)

    EMA: approved

    J07AL02
  7. pneumococcal polysaccharide conjugate vaccine (21-valent)

    CAPVAXIVE

    EMA: approved

    J07AL02
  8. pneumococcal polysaccharide conjugate vaccine (adsorbed)

    SYNFLORIX

    EMA: approved

    J07AL52
  9. polatuzumab vedotin

    POLIVY

    EMA: approved

    L01FX14
  10. polihexanide

    AKANTIOR

    EMA: approved

    S01AX24
  11. ponatinib

    ICLUSIG Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01EA05
  12. prasugrel

    PRASUGREL LUPIN

    EMA: approved Β· TGA: approved

    B01AC22
  13. propranolol

    APO-PROPRANOLOL Alphapharm Pty Ltd

    EMA: approved Β· TGA: approved

    C07AA05
  14. quadrivalent influenza vaccine (recombinant, prepared in cell culture)

    SUPEMTEK TETRA (PREVIOUSLY SUPEMTEK)

    EMA: approved

    J07BB02
  15. quizartinib

    VANFLYTA

    EMA: approved

    L01EX11
  16. radium ra223 dichloride

    XOFIGO

    EMA: approved

    V10XX03
  17. raltegravir

    ISENTRESS Merck KGaA, Darmstadt, Germany

    EMA: approved Β· TGA: approved

    J05AJ01
  18. ravulizumab

    ULTOMIRIS Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    L04AA43
  19. recombinant respiratory syncytial virus pre-fusion f protein, adjuvanted with as01e

    AREXVY

    EMA: approved

    J07BX05
  20. relatlimab

    OPDUALAG

    EMA: approved

    L01FY02
  21. remimazolam

    BYFAVO

    EMA: approved Β· NMPA: clinical trials

    N05CD14
  22. respiratory syncytial virus vaccine (bivalent, recombinant)

    ABRYSVO

    EMA: approved

    J07BX05
  23. retifanlimab

    ZYNYZ

    EMA: approved

    L01FF10
  24. rezafungin

    REZZAYO

    EMA: approved

    J02AX08

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.